ClearideBio Therapeutics raises funding

ClearideBio Therapeutics, founded in December 2025, develops antibody-drug conjugates against solid tumours. The Japanese CVC arm of LOTTE HOLDINGS is leading its pre-seed round, of undisclosed size.

Announced on
Round
Pre-seed
Amount
Amount not disclosed
Location
Basel, canton of Basel-Stadt
Sector
Biotech & life sciences

Investors

  • LOTTE HOLDINGDS Healthcare & Biopharmaceutical CVC lead

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic